feed,title,long_url,short_url
Benzinga,"Incyte Acquires Villaris Therapeutics, Deepening Portfolio For Immune-Mediated Dermatologic Diseases",https://benzinga.com/general/biotech/22/10/29117904/incyte-acquires-villaris-therapeutics-deepening-portfolio-for-immune-mediated-dermatologic-diseas,https://bit.ly/3SMeiTE
Benzinga,5 Value Stocks In The Communication Services Sector,https://benzinga.com/news/22/10/29120165/5-value-stocks-in-the-communication-services-sector,https://bit.ly/3dYXlqm
Benzinga,A Look Into Healthcare Sector Value Stocks,https://benzinga.com/news/22/10/29120121/a-look-into-healthcare-sector-value-stocks,https://bit.ly/3dYUcH2
